News UChicago Researchers Isolate Antibodies to Treat and Diagnosis COVID-19, Work to Protect Against Future Threats University of Chicago researchers have isolated SARS-CoV-2 monoclonal antibodies, which have the potential to both treat and diagnose COVID-19. Led by Patrick Wilson, a professor of medicine at the University...
News Small Business Spotlight: Urban Roots Builds Business While Building Up Their Community Jimmie Williams, owner of social enterprise landscaping and snow removal firm Urban Roots, had his most successful year ever last year. He used that success to hire additional employees and...
News Meet the Transform Cohort 2 Startups: Markison Patent Portal Team Members Tim Markison – CEO, Co-chairman, & Cofounder Dave Fallon – COO & Cofounder Dave Larsen – Chief SW Architect Jesse Woghin – Principal Product Manager Jim Dugan –...
News Chicago Booth Team Heads to Oxford for Private Equity Case Challenge Global Finals A team of four students from the University of Chicago Booth School of Business won the 2025 Water Street Private Equity Case Challenge (PECC), earning the opportunity to represent Booth...
Page Venture Gallery Venture Gallery View startups founded from across the University of Chicago ecosystem in a range of industries. Welcome to the Venture Gallery! The Polsky Center provides “first look” and early...
Program Chicago Booth and Polsky Center Private Equity Council Members The Booth Polsky Private Equity Council is comprised of some of the world’s leading private equity investors who provide ongoing guidance and support to the Polsky Center’s Svider Private Equity...
Team Amber Bradley Williams, EdD, PPS Associate Director, New Venture Challenge Associate Director, New Venture Challenge
Program Resources A suite of programs and resources designed to provide graduating students and alumni access to the education, capital, and mentorship necessary to acquire and grow small businesses.
Technology SARS-CoV-2 Monoclonal Antibodies Against Spike and Internal Proteins for Therapeutics and Diagnostics As of February 2021, there have been over 107 million cases and over 2 million deaths caused worldwide by the novel virus SARS-CoV-2. Few vaccination and treatment approaches are currently…
Technology Diagnostic Assays And Engineered Compositions For Detecting Angiotensin II Autoantibodies And Preventing Coronavirus Autoimmunity Detection and monitoring of autoantibodies against Angiotensin II in COVID-19 patients, guiding diagnosis, treatment, and vaccine design to reduce blood pressure complications and prevent harmful autoimmune responses linked to the…
Technology Broadly Neutralizing Neuraminidase Antibodies for Prophylactic and Therapeutic Treatment of Influenza One of the weaknesses of current influenza vaccines is seasonable variability in efficacy, which is predominantly caused by escape mutations in the hemagglutinin (HA) antigen, the main target of the…
Technology Neutralizing Monoclonal Antibodies Against SARS-CoV-2 The landscape of SARS-CoV-2 is experiencing a novel development of viral variants harboring mutations that can escape even the most highly potent antibodies against the receptor binding domain. These variants…
